iShares LifePath Target Date 2065 ETF (NYSEARCA:ITDI) Trading Down 0.3% – Time to Sell?

iShares LifePath Target Date 2065 ETF (NYSEARCA:ITDIGet Free Report)’s share price fell 0.3% during mid-day trading on Thursday . The stock traded as low as $39.01 and last traded at $39.16. 38,746 shares were traded during mid-day trading, an increase of 597% from the average session volume of 5,556 shares. The stock had previously closed at $39.28.

iShares LifePath Target Date 2065 ETF Price Performance

The stock has a 50-day moving average price of $38.51 and a 200-day moving average price of $37.42. The company has a market capitalization of $18.80 million, a P/E ratio of 20.19 and a beta of 0.87.

Institutional Investors Weigh In On iShares LifePath Target Date 2065 ETF

An institutional investor recently raised its position in iShares LifePath Target Date 2065 ETF stock. Heck Capital Advisors LLC lifted its holdings in iShares LifePath Target Date 2065 ETF (NYSEARCA:ITDIFree Report) by 14.7% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,763 shares of the company’s stock after buying an additional 866 shares during the period. Heck Capital Advisors LLC owned approximately 1.61% of iShares LifePath Target Date 2065 ETF worth $251,000 at the end of the most recent reporting period.

About iShares LifePath Target Date 2065 ETF

(Get Free Report)

The iShares LifePath Target Date 2065 ETF (ITDI) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2065 ITDI was launched on Oct 17, 2023 and is issued by BlackRock.

Read More

Receive News & Ratings for iShares LifePath Target Date 2065 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2065 ETF and related companies with MarketBeat.com's FREE daily email newsletter.